share_log

bluebird bio | 3: Initial statement of beneficial ownership of securities-Director Cloonan Michael

bluebird bio | 3: Initial statement of beneficial ownership of securities-Director Cloonan Michael

bluebird bio | 3:首次持股聲明-董事 Cloonan Michael
美股sec公告 ·  06/24 17:16
Moomoo AI 已提取核心訊息
Michael Cloonan, a director and 10% owner of bluebird bio, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated 06/20/2024. The document, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that Cloonan does not beneficially own any non-derivative or derivative securities of the company. The form, signed by attorney-in-fact Sydney Gaylin on 06/24/2024, confirms the reporting person's beneficial ownership status and is a standard procedure for individuals in certain positions within publicly traded companies.
Michael Cloonan, a director and 10% owner of bluebird bio, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated 06/20/2024. The document, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that Cloonan does not beneficially own any non-derivative or derivative securities of the company. The form, signed by attorney-in-fact Sydney Gaylin on 06/24/2024, confirms the reporting person's beneficial ownership status and is a standard procedure for individuals in certain positions within publicly traded companies.
Michael Cloonan 是 bluebird bio,Inc. 的董事和 10% 的股東,根據提交日期爲 06/20/2024 的 Form 3 表格向 SEC 提交了“證券利益所有權初始聲明”。這份文件是1934年證券交易法第16(a)節的要求,表明Cloonan不擁有公司的任何非衍生或衍生證券的實益所有權。該表格由代理人 Sydney Gaylin 於 06/24/2024 簽署,確認報告人的有益所有權狀態,對於某些公開交易公司內某些職位的個人而言,這是一種標準流程。
Michael Cloonan 是 bluebird bio,Inc. 的董事和 10% 的股東,根據提交日期爲 06/20/2024 的 Form 3 表格向 SEC 提交了“證券利益所有權初始聲明”。這份文件是1934年證券交易法第16(a)節的要求,表明Cloonan不擁有公司的任何非衍生或衍生證券的實益所有權。該表格由代理人 Sydney Gaylin 於 06/24/2024 簽署,確認報告人的有益所有權狀態,對於某些公開交易公司內某些職位的個人而言,這是一種標準流程。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息